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Background
Dosimetry in radiotherapy has developed dramatically in recent years with evolv-
ing technology in a period of extensive clinical development. New radiation technolo-
gies have been developed and adopted for clinical use in prostate cancer treatment in 
response to a need to deliver dose-escalated radiation therapy while minimising treat-
ment-related morbidity. This has occurred with the introduction of new advanced treat-
ment techniques, for example, volumetric modulated arc therapy (VMAT), flattening 
filter free (FFF) beams and the introduction of Magnetic Resonance Imaging Linear 
Accelerator (MRI-Linac).
Prostate cancer is the second most frequently diagnosed cancer and the sixth leading 
cause of cancer death in males, accounting for 14 % (903, 500) of the total new cancer 
cases and 6 % (258, 400) of the total cancer deaths in males in 2008 (Jemal et al. 2011). 
Radical prostatectomy, external photon beam irradiation, and brachytherapy implanta-
tion are the usual methods for treating carcinoma of the prostate. The decision of which 
procedure, or which combination of procedures, to use depends on a number factors 
such as stage, grade, and the pre-treatment prostate-specific antigen (PSA) concentra-
tion. Radioactive brachytherapy seed implants are generally used for early stage cancers, 
either as a monotherapy (100 % of the prescribed dose) or in conjunction with external 
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beam radiation therapy (67 % of the prescribed dose, referred to as a boost) (Khan and 
Gibbons 2014). The permanent transperineal interstitial placement of 125I seeds is a 
popular choice for low dose rate brachytherapy of prostate cancer. The deposited-seed 
positions are imaged and the plan optimized in real time throughout the procedure. The 
dose distribution is updated dynamically based on the actual positions as the seeds are 
deposited. The clinical and technological improvements that have emerged over the last 
decade in low dose rate prostate brachytherapy such as the use of ultrasound and com-
puted tomography-based treatment planning systems has led to a resurgence in the use 
of the technique for localized prostate cancer (Phan et al. 2009).
The purpose of radiotherapy is to safely, accurately and efficiently deliver radiation to 
treat various types of cancers. Recently, a number of radiation incidents in various coun-
tries have been reported (Mayles 2007; Williams 2007; Derreumaux et al. 2008; Shafiq 
et  al. 2009). The examples discussed in these reports demonstrate that newly devel-
oped radiation treatment techniques, and their implementation into the clinic, require 
an increasing level of alertness to verify the safe and accurate delivery of the prescribed 
treatment. To address these issues comprehensive quality assurance (QA) programs have 
been introduced. These programs should verify the correct functioning of all compo-
nents in the radiotherapy chain including the treatment planning system (TPS)—against 
known tolerances—and treatment delivery system. In addition to these QA programs 
of the separate components required for a patient treatment, additional pre-treatment 
verification checks for individual patients are often performed using, for instance, inde-
pendent dose or monitor unit (MU) calculation programs, and various QA devices such 
as ionization chamber and diode arrays.
A dosimeter is defined as a device that provides a reading that is a measure of the 
average absorbed dose deposited on its measuring body by ionising radiation. Codes of 
practice in the United Kingdom (Lillicrap et al. 1990; Thwaites et al. 2003) define how 
the dosimetric calibration of clinical beams is undertaken with ionization chamber rec-
ommendations. While there are many types of radiation dosimeters available, there is no 
single dosimeter that can detect all the different forms of radiation, and consequently, 
different types of dosimeters may be required to detect different forms of radiation 
depending on the application. Based on the application, an informed decision will be 
required for the type of dosimeter to be used.
In vivo dosimetry is the most direct method for monitoring the dose delivered to the 
patient receiving radiation therapy. When performed early in treatment, as a supplement 
to the clinical quality assurance (QA) program, simple in  vivo measurements are an 
additional safeguard against major setup errors and calculation or transcription errors 
that were missed during the pre-treatment chart check. In the absence of errors, routine 
in vivo measurements uniquely document that treatment was delivered correctly within 
a user-specified tolerance. Unlike other QA methods, in vivo dosimetry checks the dose 
delivered to the patient rather than the individual components prior to treatment. There 
is a growing interest in the need to perform such in vivo measurements in part owing to 
increasing awareness of the potential risks associated with incorrect delivery or plan-
ning of radiation treatments, and because of the use of increasing complex delivery tech-
niques such as intensity-modulated radiation therapy (IMRT) and VMAT, and the move 
towards more hypofractionated treatments delivered with large doses per fraction.
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The initial motivation for performing in vivo dosimetry (IVD) in brachytherapy was 
mainly to assess doses to organs at risk (OAR) by direct measurements, because pre-
cise evaluation of OAR doses was difficult without 3D dose treatment planning. With 3D 
image-guided brachytherapy now the norm, it is now possible to calculate 3D tumour 
and OAR doses as well as dose volume histogram (DVH) parameters by the treatment 
planning system (TPS). However, there are situations where significant dose calculation 
uncertainties exists, in particular for low-energy photon-emitting sources (Iodine 125) 
and here IVD would contribute to more precise dose reporting. Furthermore, poten-
tial organ movement in between imaging and treatment contributes to uncertainties 
in delivered dose, and IVD have a potential role for identification of organ or applica-
tor movements. Brachytherapy is typically administered with large doses per fraction 
(>5  Gy), which means that the consequence of a fractional error may be substantial 
when compared to typical external beam radiotherapy (EBRT) with delivery of smaller 
doses per fraction (e.g. 2 Gy). IVD is extremely important in brachytherapy as an inde-
pendent method for detection of deviations or errors. However, for certain clinical situ-
ations TPS based dose calculations are currently associated with systematic deviations 
due to lack of corrections for heterogeneities and scatter conditions. This is particularly 
true for low-energy sources such as Iodine 125or 103Pd used in permanent implants of 
prostate. Some dosimetry systems define specific points or volumes for dose reporting 
for individual patients such as the American Brachytherapy Society (Davis et al. 2012) 
and this kind of reporting is important for patient related outcome measures (PROMS). 
In the situation where the tumour and OARs move and/or get deformed, as is the case 
during permanent prostate implants, IVD can provide additional information about the 
dose delivered to the tumour and/or OAR for the given patient. Future developments 
would have to be focused on the back end of the detection system utilised to process the 
data (i.e. the readings of the detector) with automatic data display, requiring less man-
power, with no post data analysis or special expertise needed. Furthermore, to be suc-
cessful for widespread use, any new technological innovation for such systems will have 
to be well integrated into the routine clinical application being targeted. Given existing 
alternatives for accurate brachytherapy dosimeters, future requirements will likely be 
made on in vivo dosimetry systems that can monitor the dose in real time, are sensitive 
to displacements of all applicators involved in the treatment, can identify organ motion, 
and that can provide immediate alerts of any potential gross error during ongoing treat-
ments which alerts the clinician. The most common clinical in vivo dosimetry systems 
used are thermoluminescent detectors (TLDs), metal-oxide semiconductor field effect 
transistors (MOSFET), diodes, film and electronic portal imaging devices (EPIDs). These 
systems have advantages and disadvantages based on their application and are fully 
reviewed by Mijnheer et al. (2013). Not long after their clinical introduction for setup 
verification, it was realised that EPID images contain dose information. Consequently, 
several groups investigated the dosimetric characteristics of various types of EPIDs 
(Elmpt et al. 2008). Interest and development in EPID dosimetry has been accelerated 
by the advantages of fast image acquisition, high resolution, digital format, larger EPIDs 
with improved technology (Mijnheer et  al. 2013). However, such technology requires 
an increased investment in dosimetry and associated hardware to support it. With the 
ongoing development, and soon to be commercially released, MRI-Linac (Stefanowicz 
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et al. 2013), there has been an increased focus on other forms of in vivo dosimetry sys-
tems, such as optically stimulated luminescent dosimeters, radioluminescence dosim-
eters, plastic scintillation dosimeters and implantable MOSFETs (Reynolds et al. 2013).
Properties of radiotherapy dosimeters
The accuracy of any dosimeter measurement is the ratio of expected value to that of 
the actual measured radiation. The precision of dosimetry measurements specifies the 
reproducibility of the measurements under similar conditions and can be estimated 
from the data obtained in repeated measurements. High precision is associated with a 
small standard deviation of the distribution of measurement results (Podgorsak 2005).
Ideally, the dosimeter reading should be linearly proportional to the dosimetric quan-
tity. However, beyond a certain dose range a non-linearity generally sets in. The linearity 
range and the non-linearity behaviour depend on the type of dosimeter and its physi-
cal characteristics. In general, a non-linear behaviour should be corrected for. A dosim-
eter and its reader may both exhibit non-linear characteristics, but their combined effect 
could produce linearity over a wider range.
Integrating systems measure the integrated response of a dosimetry system. For such 
systems the measured dosimetric quantity should be independent of the rate of that 
quantity. Ideally, the response of a dosimetry system at two different dose rates should 
remain constant. In reality, the dose rate may influence the dosimeter readings and 
appropriate corrections are necessary, for example, recombination corrections for ioni-
zation chambers in pulsed beams in external beam radiotherapy.
The response of a dosimetry system is generally a function of radiation beam quality 
(energy). Since the dosimetry systems are calibrated at a specified radiation beam qual-
ity (or qualities) and used over a much wider energy range, the variation of the response 
of a dosimetry system with radiation quality (called energy dependence) requires cor-
rection. Ideally, the energy response should be flat (i.e. the system calibration should be 
independent of energy over a certain range of radiation qualities) enabling the dosimetry 
system to be used with various energies in both external beam radiotherapy and brachy-
therapy. In reality, the energy correction has to be included in the determination of the 
quantity for most measurement situations. In radiotherapy, the quantity of interest is the 
dose to water (or to tissue). As no dosimeter is water or tissue equivalent for all radiation 
beam qualities, the energy dependence is an important characteristic of a dosimetry sys-
tem. Energy dependence has implications both for calibration of the dosimeter and for 
conversion of detector reading into measured dose during patient measurements. Most 
commonly used detectors exhibit higher energy dependence in brachytherapy than in 
megavoltage beams, because the photoelectric effect causes an over-response in the 
brachytherapy energy range.
The variation in response of a dosimeter with the angle of incidence of radiation is 
known as the directional, or angular, dependence of the dosimeter. Dosimeters usually 
exhibit directional dependence, due to their constructional details, physical size and 
the energy of the incident radiation. Therapy dosimeters are generally used in the same 
geometry as that in which they are calibrated. Directional independence is a very impor-
tant characteristic in the field of LDR (low dose rate) brachytherapy due to the individual 
Iodine-125 seed placement which results in various orientations.
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Since the dose is a point quantity, the dosimeter should allow the determination of 
the dose from a very small volume (i.e. one needs a ‘point dosimeter’ to characterize the 
dose at a point). The position of the point where the dose is determined (i.e. its spatial 
location) should be well defined in a reference coordinate system. Environmental vari-
ations such as temperature, pressure and humidity can cause variations in dosimeter 
readout; corrections to the measured dose may need to be implemented with a reference 
reading subtracted from measured reading.
Dosimeters should be rugged, easy to handle and not affected by the radiation itself. 
Dosimeters can be either active or passive types. Active dosimeters measure radiation 
exposure in real time with immediate results of radiation detected. Passive dosimeters 
do not provide real-time results, this is provided post-irradiation. Active type dosim-
eters provide numerous advantages over passive type dosimeters such as instant or 
direct reading of radiation levels which is now an ideal requirement. This paper presents 
a review of the state-of-the-art in optical fibre based sensor technology for radiation 
dosimetry in oncology. The work provides an introduction to the different techniques 
used and an overview of the developments in the application of these sensors to radio-
therapy, specifically external beam radiotherapy and low dose rate (LDR) and high dose 
rate (HDR) brachytherapy. The authors have focussed their attention on prostate can-
cer and where possible an example of the sensor type implemented in a prostate cancer 
treatment environment is provided.
Optical fibre dosimeters
Optical fibre dosimeters can have many advantages over existing systems such as TLDs, 
diodes or MOSFETs. A significant advantage is that optical fibres are composed of silica 
(glass) or plastic resulting in a material perfectly suited for the use in an MRI environ-
ment, as they are non-magnetic and do not cause interference of the image, immune to 
intense magnetic fields and radiofrequency (RF) present in this environment (Raaymak-
ers et al. 2009). Optical fibres can also be summated together (multiplexed) to a single 
controller which in turn can form an array of detectors for 2d measurements. The devel-
opment of radiation-resistant fibres has also meant that optical fibres can be utilised in 
areas of high levels of radiation. The small size of optical fibre sensors offers significant 
advantages for application in prostate brachytherapy. The small dimensions of the sensor 
(as low as 250 µm diameter) allows it to be easily guided within existing brachytherapy 
equipment; for example, within the seed implantation needle for direct tumour dose 
analysis, in the urinary catheter to monitor urethral dose, or within the biopsy needle 
holder of the transrectal ultrasound probe to monitor rectal wall dose. The measured 
radiation dose can be used to verify the calculated dose distribution that describes the 
treatment received by the patient. The availability of real-time radiation dose measure-
ments during the brachytherapy procedure will allow for optimisation of the brachy-
therapy seed insertion during the procedure and result in high quality treatments. The 
quality of a brachytherapy treatment is directly linked to patient survival and outcomes 
(Hinnen et al. 2010). Radiation dosimetric methods are used for the estimation of dose 
absorbed by radiation in a detector material using either thermoluminescence (TL) 
technique or optically stimulated luminescence (OSL) technique or radioluminescence 
(RL) or any other technique using passive solid state detectors.
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Luminescence dosimetry
Luminescence occurs when a material is subjected to radiation and that material absorbs 
some of the radiation and as a result, emits light with a different wavelength. The wave-
length of the emitted light is dependent on the luminescence material. Different types 
and forms of radiation can be used to excite a material and it is these types of radiation 
which give rise to different types or methods of luminescence. These are thermolumi-
nescence (excitation due to heat), photoluminescence (excitation due to optical or ultra 
violet light) and radioluminescence (excitation is due to alpha, beta, gamma or x-rays).
Thermoluminescence dosimetry
Thermoluminescence (TL) is the emission of light from a solid due to heating, after it 
has previously been excited by radiation. When exposed to radiation, the TL material 
absorbs energy, which it then stores until it is heated. Germanium-doped silica (Ge-
doped SiO2) type optical fibres have been demonstrated as potential novel forms of ther-
moluminescence dosimeters for radiation therapy dosimetry (Ramli et al. 2009). Abdul 
Rahman et al. (2012) performed an investigation in November 2011 into the ability of a 
high spatial resolution (~120 µm) Ge-doped SiO2 fibre thermoluminescence dosimeter 
to measure radiation. The optical fibres demonstrated good reproducibility (±1.5  %), 
at fixed dose rate, the dosimeters were found to produce a flat response of better than 
4 % (1 S.D) of mean TL distribution and showed good linearity (r2 = 0.998) of response 
up to a dose of 50 Gy for photon and electron beams. Entezam et al. (2016) reviewed 
the response behaviour, the fibres showed good reproducibility, energy, and field-size 
response, it was demonstrated that dependency on the field size for the most sensi-
tive sample (the 42 µm core size fibre) was determined for photons produced at 6- and 
10 MV and field sizes of 3, 6, 8, 10, 20, 25 and 30 cm. For each field size, measurement 
was carried out for five fibre segments of the 42 µm core size fibre, the results being nor-
malized for all field sizes using the obtained value for 10 × 10 cm2 field size (Fig. 1).
Fading, the reduction of TL response as a function of time post-irradiation, depends 
primarily on parameters such as storage temperature and radiation type. The analysis 
of fading for flat and cylindrical fibres, fabricated by members of this group has been 
Fig. 1 Sensitivity dependency of the 42 µm core size fibre on field size, measured for 6 MV X-rays. Repro-
duced from Entezam et al. (2016) with permission from Elsevier
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determined by Ghomeishi et al. (2015). For flat and cylindrical fibres irradiated simulta-
neously to a dose of 8 Gy using 6 MV photons, 15 days post-irradiation the TL response 
for the flat and cylindrical fibres had reduced by 17 and 27 %, respectively, compared to 
that obtained a day after irradiation.
One advantage of Ge-doped Si optical fibre dosimeters is that they are water resistant, 
and therefore, it becomes possible to locate the fibre dosimeter within a particular tissue 
of interest; this suggests the possible use of Ge-doped SiO2 optical fibres in a variety of 
interface dosimetry situations, as in the application of radiation synovectomy (Karavida 
and Notopoulos 2010). The potential radiotherapy dosimetric applications for doped sil-
ica fibres as TLDs have been reviewed by Bradley et al. (2012). The use of Ge-doped sil-
ica fibres has also been proposed by Issa et al. (2012) in brachytherapy, the optical fibres 
dosimeters have been employed in obtaining doses at distances very close to the source 
(2 mm). Dose measurements, obtained for separations from 2 up to 20 mm, were found 
to be in good agreement with simulations of photon-mediated dose obtained using the 
DOSRZnrc Monte Carlo code with agreement within 3 and 1 % for the 133Ba and 60Co 
sources, respectively. A significant disadvantage of thermoluminescent dosimetry is that 
the dose information is dependent on the post-irradiation of the material and so real-
time dosimetry is not possible.
Optically stimulated luminescence
In a similar process to thermoluminescent techniques, photoluminescence, or opti-
cally stimulated luminescence (OSL), emits the energy stored owing to irradiation, upon 
exposure to light. When the insulator or semiconductor is subjected to radiation, elec-
tron hole pairs are generated, defects in the OSL material trap these electron hole pairs. 
This illumination of the material, frees the trapped electron hole pairs with the result of 
luminescence from the material transmitted through the fibre and measured with a pho-
tomultiplier tube.
Carbon-doped aluminium oxide (Al2O3:C) (Yukihara et  al. 2014) showed how the 
response from OSL is linear and independent of energy and dose rate, exhibits little fad-
ing, temperature dependent and is sensitive to light. Europium-doped potassium bro-
mide (KBr:Eu) were reviewed by McKeever (2011). It was discovered that the signal from 
KBr:Eu is unstable due to fading at room temperature, rapid OSL decay and its simpler 
process of OSL production enables the material to be used in real-time monitoring of 
radiation. Enhanced aluminium oxide doped with carbon and magnesium (Al2O3:C,Mg) 
(Rodriguez et al. 2011) were investigated for optically stimulated luminescence (OSL) in 
radiation dosimetry. Findings show that the intensities of TL, OSL and RL signals of the 
samples were similar to that of regular carbon-doped aluminium oxide (Al2O3:C).
Dunn et  al. (2013) commissioned optically stimulated luminescence dosimeters 
(OSLDs) as a replacement for thermoluminescence dosimeters (TLDs) for applica-
tion within radiotherapy, a product from Landauer Inc. known as “nanoDots” showed 
supra-linearity, reproducible fading (3 %) and little signal depletion per readout (0.03 %). 
Marckmann et al. (2006) developed a novel idea to overcome Cerenkov radiation by cou-
pling OSL (Al2O3:C) to the end of a polymethyl methacrylate (PMMA) optical fibre to 
result in simultaneous RL/OSL signals providing real-time radiation monitoring using 
RL and post-radiation using OSL. The characterisation of a fibre based Al2O3:C OSL 
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dosimeter by Anderson et al. (2009) for its response to 192Ir, demonstrates the suitabil-
ity of such a device for HDR brachytherapy. The system demonstrated excellent linearity 
in the tested dose rage (0–4.3 Gy), with reproducibility of approximately 1.3 %. It was 
also estimated that measurements with a 5–50 mm source to probe distance would be 
associated with a 5 % uncertainty.
Radioluminescence
Plastic scintillating fibre dosimeters Scintillating fibres work by converting incident 
radiation energy into visible light, as they are exposed to X-ray radiation, electrons in 
the fibre are excited to higher energy levels through either Compton or photoelectric 
effect. The fibre core is doped with scintillating fluorescent particles, which fluoresce 
when irradiated by ionising radiation, and cladded with PMMA. A major advantage of 
these dosimeters in radiotherapy is their water equivalence making them an ideal dosim-
eter in radiotherapy dosimetry. However, recent studies (Buranurak et al. 2013) identified 
the effect of temperature on a fibre coupled organic plastic scintillator in applications 
such as external beam radiotherapy and brachytherapy. The study showed that the light 
yield in the peak regions of the scintillators decreases linearly with increasing tempera-
ture. Temperature coefficients of −0.15 ± 0.01 and −0.55 ± 0.04 % K−1 for blue BCF-12 
and green BCF-60 from Saint-Gobain Crystals were, respectively, observed in the study. 
Another study (Beddar 2012) showed significant differences from measurements inside 
patients to those measurements in anthropomorphic phantoms due to the similar effects 
of temperature.
Figure 2 shows the properties of four scintillating organic fibres which were used from 
Saint-Gobain Crystals (2015). These were BCF10, BCF12, BCF20 and BCF60. It shows 
that BCF10, BCF12 emit a blue colour whereas BCF20, BCF60 both emit a green colour 
with a resultant higher emission peak. They range from 0.25 to 5.00  mm in diameter, 
have a polystyrene core with fluorescent dopants and a PMMA cladding.
Suchowerska et  al. (2011) showed a fibre optic scintillating dosimeter, consisting of 
a plastic scintillator coupled to an optical fibre for brachytherapy. These sensors were 
small enough (0.5 mm) to be inserted into a No. 16 French urinary catheter, to perform 
in vivo dosimetry to determine the urethral dose during high dose rate (HDR) treatment 









# of Photons 
per MeV 
Characteristics/ Applications 
BCF-10 Blue 432 2.7 2.2 ~8000 General purpose; optimised for 
diameters >250µm 
BCF-12 Blue 435 3.2 2.7 ~8000 Improved transmission for use in 
long lengths 
BCF-20 Green 492 2.7 >3.5 ~8000 Fast green scintillator 
BCF-60 Green 530 7 3.5 ~7100 3HF formulation for increased 
hardness 
Fig. 2 Four examples of scintillating fibres from Saint-Gobain Crystals (McKeever 2011)
Page 9 of 16Woulfe et al. Cancer Nano  (2016) 7:7 
0.1  % of the signal and the sensor had the capability of real-time readout. Klein et  al. 
(Klein et al. 2012) demonstrated a plastic scintillating fibre (BCF-60) mounted onto an 
endorectal balloon to verify doses in vivo during intensity-modulated radiation therapy 
(IMRT) and volumetric arc therapy (VMAT) for prostate cancer. The sensor measured 
doses that correlated with ionization chamber measurements and it was found that 
treatment planning system calculations were within 1 % of expected values. A proposed 
dosimeter for in  vivo dosimetry in HDR brachytherapy was investigated (Therriault-
Proulx et al. 2013), whereby a single fibre with multipoint plastic scintillators was devel-
oped for Iridium-192 HDR brachytherapy treatment verification in a water phantom. It 
contained a three-point detector containing BCF-10, BCF-12 and BCF-60 scintillating 
elements. A comparison of measured doses at different source-to-detector distances 
were investigated, with the result that the system was suitable for measuring source 
position uncertainty to less than 0.32 ± 0.06 mm.
A clinical trial of a plastic scintillating fibre dosimeter, BrachyFOD, (Suchowerska 
et al. 2011) enrolled 24 patients receiving HDR brachytherapy to the prostate. After 14 
patients, the dosimeter design was improved for more accurate readings to improve clin-
ical reliability: a dosimeter self-checking facility; a radiopaque marker to determine the 
position of the dosimeter, and a more robust optical extension fibre as depicted in Fig. 3. 
The results demonstrated a maximum measured dose difference of 9 % from the calcu-
lated dose from the TPS for the remaining patients in the trial indicating the importance 
of in vivo dosimetry in brachytherapy.
In a further study (Gagnon et al. 2012), the performance of a plastic scintillator BCF-
60 was compared with a range of traditional small field dosimeters for stereotactic QA, 
the results compared output factors and dose profiles with a good level of agreement 
with diodes and EBT2 Gafchromic film. Currently, the only commercial optical fibre 
dosimeter for radiotherapy is the Standard Imaging Exradin W1 Scintillator (2014), a 
1 mm core polystyrene-based fibre that is coupled to a PMMA optical fibre for transmis-
sion of the optical signal.
Inorganic scintillating fibre dosimeters Inorganic scintillators are generally in crystal form 
grown at high temperatures. They are made of alkali halides, or oxides, and often require an 
Fig. 3 a Design of the BrachyFOD. a 4-mm-long 0.5-mm diameter Bicron BC400 scintillator is coupled to a 
0.5-mm diameter (0.48-mm core) polymethyl methacrylate (PMMA) PMMA optical fibre. The entire dosimeter 
is covered with a black polyvinyl toluene PVT buffer tubing. b Design of the RFOD. The scintillator, spacer, and 
platinum radiopaque marker are all 0.5 mm in diameter and 4 mm long. Reproduced from Suchowerska et al. 
(2011) with the permission from Elsevier
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activator impurity, e.g. Na(Tl), CsI(Tl). Due to the crystal form of the scintillator, it is pos-
sible to incorporate the material into the sensing region in a number of different ways, e.g. 
coating the fibre, coupling it to the time, or embedding it within the fibre. Distinct advan-
tages include real-time dosimetry, small size and good spatial resolution. In evaluating the 
scintillation efficiencies of different phosphors, a radiation dosimeter (Jang et al. 2011) to 
detect tritium in real time was developed, composed of a scintillator material, an optical 
fibre bundle and alight measuring device, as illustrated in Fig. 4. Each scintillator interacts 
with electron or beta radiation and generates scintillation photons between 455 nm and 
550 nm wavelength of light. Three kinds of inorganic scintillators were tested at different 
distances between the fibre optic sensor and source. These were Gd2O2S:Tb, cerium-doped 
YAG (Y3Al5O12:Ce) and CsI:Tl. The results show that the scintillation efficiencies of CsI:Tl, 
Y3Al5O12:Ce and Gd2O2S:Tb are 8, 5 and 15 %, respectively. The Gd2O2S:Tb type scintilla-
tor was found to give the greatest scintillation response of photons.
An optical fibre dosimeter has been developed by McCarthy et al. (2011; O’Keeffe et al. 
2013) by coating the end of an exposed PMMA optical fibre, after the cladding has been 
removed, with Gd2O2S:Tb. The scintillating phosphor, supplied by Phosphor Technolo-
gies Ltd (2014) is mixed with an epoxy mix and injected into a cylindrical mould con-
taining the exposed PMMA fibre optic core and allowed to cure. The radiation-sensitive 
scintillating material tip of the sensor fluoresces on immediate exposure to ionising 
radiation. The resultant emitted fluorescent light penetrates the PMMA optical fibre and 
propagates along the fibre to a distal scientific grade spectrometer from Ocean Optics 
(Dunedin, FL), where the intensity of the peak wavelength of the fluorescent light is meas-
ured. Initial characterization measurements of this sensor have been carried out, with 
its response being evaluated in water equivalent phantoms to assess whether it would 
be suitable for potential in  vivo applications in either brachytherapy or external beam 
radiotherapy dosimetry. The results demonstrate that the fibre has a high sensitivity and 
good repeatability across a range of beam energies and types, and demonstrate a linear 
response from low doses of the order of centigray up to at least 16 Gy in a single delivery.
An optical fibre sensor (Woulfe et  al. 2016) based on radioluminescence, whereby 
radiation-sensitive scintillation material is embedded in the core of a plastic optical 
fibre, is illustrated in Fig. 5. Three sensors were fabricated, using different inorganic scin-
tillators, identified as being most suitable for brachytherapy applications: thallium doped 
Fig. 4 Fiber-optic sensor tip to detect beta rays. a Schematic diagram of sensor tip and b picture of sensor 
tip. Reproduced from Jang et al. (Jang et al. 2011) with permission from Elsevier
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caesium iodide (CsI:Tl), terbium doped gadolinium oxysulphide (Gd2O2S:Tb, GOS) and 
europium-doped lanthanum oxysulphide (La2O2S:Eu, LOS). Terbium doped gadolinium 
oxysulphide (Gd2O2S:Tb, GOS) demonstrated the highest sensitivity to the 125I brachy-
therapy seeds (Woulfe et al. 2016). The sensor is designed for in vivo monitoring of the 
radiation dose during radioactive seed implantation for low dose rate brachytherapy, 
in prostate cancer treatment, providing oncologists with real-time information of the 
radiation dose to the target area and/or nearby critical structures. The radiation from 
the brachytherapy seeds causes emission of visible light from the scintillation material, 
which penetrates the fibre, propagating along the optical fibre for remote detection using 
a multi-pixel photon counter. The sensor demonstrates a high sensitivity to Iodine-125, 
the radioactive source most commonly used in brachytherapy for treating prostate can-
cer. The developed optical fibre based sensor has a number of significant advantages 
for application in brachytherapy. The small dimensions of the sensor allow them to be 
guided within existing brachytherapy equipment; for example, within the seed implan-
tation needle (see Fig.  5b), in the urinary catheter to monitor urethral dose, or along 
the transperineal ultrasound probe to monitor rectal wall dose. This allows for real-time 
monitoring of the radiation dose to the target area or nearby critical structures. Fur-
thermore, the construction of the sensors is such that they are completely biologically 
separate from their monitoring environment, and therefore, offer no possibility of con-
tamination or other form of threat to their target operating environment, i.e. internal 
human tissue.
Fibre Bragg gratings Fibre Bragg grating (FBG) based sensors work by monitoring the 
wavelength shift of the returned Bragg signal which changes as a function of the meas-
ured. The Bragg wavelength is related to the refractive index of the material and the grat-
ing pitch. The light incident on the grating reflects a narrow spectral component at the 
Bragg wavelength, and hence in the transmission spectrum this component is missing. 
Work (Mihailov 2012) has concentrated on developing radiation-resistant FBGs for use 
in temperature and strain measurement applications in nuclear environments.
The outcome of a project investigating the use of FBGs as high dose radiation sensors 
was first presented by Krebber et al. (2006). The work is based on the Kramer–Kronig 
dispersion relations, which can be used to show that an increase of attenuation has to 
be accompanied by a change of refractive index. The FBGs were written in a hydrogen 
doped Ge-doped fibre for wavelengths of 650, 820, 1285 and 1516  nm. The radiation 
induced refractive index change was calculated from the Bragg wavelength shift and 
Fig. 5 Optical fibre based radioluminescent radiation probe for in vivo brachytherapy. a Optical fibre based 
radiation probe for in-vivo brachytherapy. b Optical fibre sensor within brachytherapy needle for direct 
tumour dose monitoring. Reproduced from Woulfe et al. (2016) with permission from SPIE
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a wavelength shift from 850 to 1216 nm was demonstrated to be independent of dose 
rate for radiation doses greater than 2 kGy. Although small changes in temperature are 
accounted for within the sensor system, the sensor requires a highly stable setup, with 
stress-free attachment of the FBG along with a constant, steady temperature. Fibre Bragg 
gratings, written in Ge‐doped silica fibres, have been shown to be capable of monitoring 
high‐radiation doses (Avino 2014).
Cerenkov radiation (stem effect)
One of the primary disadvantages of using plastic scintillation detector systems is the 
generation of radiation induced light. This light is a form of noise in the received spec-
trum of light. It can be attributed to Cerenkov emission. A term known as the stem 
effect is used to describe Cerenkov light and other light which can be produced in a scin-
tillation optical fibre dosimeter. Cerenkov radiation is generated when a charged parti-
cle passes through a medium with a velocity greater than that of light in that medium. 
Cerenkov emission only occurs when the refractive index of the material is greater than 
one. This emission of light generates a cone of light which spreads out at an angle. Cer-
enkov emissions are only produced above a certain energy threshold. For any radiation 
with energy below this threshold level, the presence of fluorescent light generated in the 
optical fibre should be considered. A number of different techniques have been shown 
to minimise the effects of Cerenkov light. These are background subtraction, filtering, 
and chromatic removal. These techniques help separate and remove the stem effect from 
the radiation signal (Archambault et al. 2006). The background subtraction is done by 
placing a second bare optical fibre next to the original sensing fibre. The bare fibre also 
produces the Cerenkov radiation and can be subtracted from the sensing fibre. The sec-
ond method called spectral discrimination uses a colour CCD camera to measure both 
the scintillation and Cerenkov signal over different wavelength ranges. The Cerenkov is 
subtracted with the result that the scintillation signal is left behind. The third method is 
chromatic separation of the signal and Cerenkov emissions, through the use of optical 
filters. Another method of using a rigid air core light guide between the scintillator and 
the optical fibre was proposed to prevent Cerenkov light production (Law et al. 2006). 
Work by Law et al. have shown that both Cerenkov and fluorescent light generated in 
an optical fibre contribute a varying background signal that depends on the length of 
fibre exposed to radiation. They showed that the magnitude of the Cerenkov and fibre 
fluorescence is between 1 and 0.1 % of the signal, for the same source to fibre scintillator 
distance. Yoo et al. (2013) fabricated a novel fibre optic Cerenkov radiation sensor for 
measuring beta particles. Instead of using a scintillator, transparent liquids with various 
refractive indices were used as a Cerenkov radiator which served as a sensing material. 
The results showed that the amount of Cerenkov radiation due to low energy beta parti-
cles increased as the refractive index of the Cerenkov materials was increased.
Dosimeter characteristics summary
An overview of the various types of dosimeters is depicted in Table 1 characterising their 
applications with emphasis on both advantages and disadvantages.
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Conclusions
Radiation dosimetry has gained huge interest from many scientific disciplines and has 
led to the development of a huge number of publications across all the different types 
of dosimeter interests. This paper reviews a number of optical fibre based methods of 
dosimetry for radiation monitoring in prostate cancer therapy. Their small size, light-
weight and flexibility have allowed their dosimetric performance to be demonstrated 
successfully in a range of measurement scenarios and have been demonstrated as being 
particularly effective for in vivo dosimetric verification of treatments such as HDR and 
prostate seed brachytherapy. Table 1 summarises the main characteristics of the prin-
ciple radiotherapy dosimetry techniques based on optical fibres. Radioluminescence is 
the predominant technique used with RL showing the most potential within the area of 
in vivo dosimetry. PSDs have demonstrated significant advantages in the area of radi-
otherapy dosimetry, owing to their near-water equivalence, and this is reflected in the 
increasing number of publications in this area. Commercial interest has also focused 
on PSDs with the first optical fibre dosimeter for radiotherapy applications to reach the 
market, the Exradin W1, based on this technology, and further PSDs are also set to enter 
the market shortly. However, the recent reports on temperature dependence of this type 
of dosimeter must be investigated, and if necessary, accounted for, to ensure the reliabil-
ity of the measurements.
Given existing alternatives for accurate brachytherapy dosimeters, future advance-
ments will likely be made on in  vivo dosimetry systems that can monitor the dose in 
real time, are sensitive to displacements of all applicators involved in the treatment, can 
identify organ motion, and that can provide immediate alerts of any potential gross error 
during ongoing treatments. Multiplexing of existing single-point optical fibre sensors 
will also play an important role in the future, allowing for volumetric dose measure-
ments. Recently, it has been shown that it is possible to develop detectors composed 
of multiple different colour PSDs (mPSD) using a single optical transmission line and 
capable of measuring the dose accurately (François et al. 2012). Insertion of additional 
detector catheters may be performed with the purpose of optimizing detector position-
ing, e.g. by inserting an additional interstitial needle for housing a dosimeter probes 
in the tumour region. A smaller invasive impact may be achieved by inserting a steri-
lized dosimeter in the urethral catheter for urethral dose measurements. With a gamma 
analysis, an error criterion would be based not only on a dose difference but could also 
combine it with a distance-to-agreement criterion. In such an analysis, the upfront 
knowledge of the geometrical uncertainties of the detector and source positioning could 
be incorporated into the model to decide on relevant distance-to-agreement criteria.
It is the opinion of the authors that optical fibre sensors have an important role to 
play in in vivo dosimetry in radiotherapy for prostate cancer, providing direct real-time 
monitoring of the radiation delivered to the prostate and nearby critical structures, such 
as the urethra and rectal wall.
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